Terug
Dagbereik
€ 17,68
€ 18,55
52-Weeksbereik
€ 7,80
€ 20,25
Volume
436.030
50D / 200D Gem.
€ 17,05
/
€ 14,56
Vorige Slotkoers
€ 18,39
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -14,6 | 0,3 |
| P/B | 2,0 | 2,9 |
| ROE % | -19,1 | 3,7 |
| Net Margin % | — | 3,8 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,0 | 0,2 |
Koersdoel Analisten
Hold
€ 20,00
+10.1%
Low: € 14,00
High: € 28,00
Forward WPA
-€ 3,03
Omzet Sch.
0
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2029 |
-€ 2,04
-€ 2,04 – -€ 2,04
|
190 M | 6 |
| FY2028 |
-€ 3,08
-€ 4,41 – -€ 2,20
|
64 M | 8 |
| FY2027 |
-€ 3,14
-€ 4,07 – -€ 2,12
|
0 | 8 |
Belangrijkste Punten
Debt/Equity of 0,00 — conservative balance sheet
Negative free cash flow of -74,82M
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-19,14%
ROIC-12,54%
Net MarginN/A
Op. MarginN/A
Veiligheid
Debt / Equity
0,00
Current Ratio27,93
Interest Coverage0,00
Waardering
P/E Ratio
-14,63
P/B Ratio2,02
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0,0 | Net Income (TTM) | -68,00M |
| ROE | -19,14% | ROA | -11,95% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -74,82M |
| ROIC | -12,54% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,00 | Current Ratio | 27,93 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -14,63 | P/B Ratio | 2,02 |
| P/S Ratio | N/A | PEG Ratio | -0,56 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 994,80M | Enterprise Value | 505,82M |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 |
|---|---|---|---|
| Revenue | 0,0 | 0,0 | 0,0 |
| Net Income | -68,00M | -51,99M | -37,85M |
| EPS (Diluted) | -1,25 | -1,00 | -0,73 |
| Gross Profit | 0,0 | 0,0 | 0,0 |
| Operating Income | -82,39M | -39,89M | -37,66M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 |
|---|---|---|---|
| Total Assets | 569,20M | 233,98M | 6,70M |
| Total Liabilities | 77,32M | 15,47M | 23,98M |
| Shareholders' Equity | 491,88M | 218,51M | -17,28M |
| Total Debt | 738.000,0 | 657.000,0 | 0,0 |
| Cash & Equivalents | 489,71M | 230,44M | 4,16M |
| Current Assets | 502,53M | 231,07M | 4,98M |
| Current Liabilities | 17,99M | 15,09M | 23,90M |